Showing 1 - 3 results of 3 for search 'Lennart I Persson', query time: 0.02s Refine Results
  1. 1
    A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis.

    A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis. by Ann Logan, Zsuzsanna Nagy, Nicholas M Barnes, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giuseppe Lazzarino, Giacomo Lazzarino, Lars Bruce, Lennart I Persson

    Published 2022-01-01
    Get full text
    Article
  2. 2
    A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis

    A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis by Ann Logan, Zsuzsanna Nagy, Nicholas M. Barnes, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giuseppe Lazzarino, Giacomo Lazzarino, Lars Bruce, Lennart I. Persson

    Published 2022-01-01
    Get full text
    Article
  3. 3
    ILB<sup>®</sup> Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral Sclerosis

    ILB<sup>®</sup> Attenuates Clinical Symptoms and Serum Biomarkers of Oxidative/Nitrosative Stress and Mitochondrial Dysfunction in Patients with Amyotrophic Lateral Sclerosis by Giacomo Lazzarino, Renata Mangione, Antonio Belli, Valentina Di Pietro, Zsuzsanna Nagy, Nicholas M. Barnes, Lars Bruce, Bernardo M. Ropero, Lennart I. Persson, Benedetta Manca, Miriam Wissam Saab, Angela M. Amorini, Barbara Tavazzi, Giuseppe Lazzarino, Ann Logan

    Published 2021-08-01
    Get full text
    Article

Search Tools: